In the past small for dates babies have caused appreciable concern to their medical attendants. According to the 1958 perinatal mortality survey infants with birth weight -2500 g born after full duration or prolonged pregnancies had a mortality eight times higher than those weighing >2500 g.1
The danger of symptomatic hypoglycaemia was first recognised in 1959.2 Many other neonatal complications, such as birth asphyxia, hypothermia, sepsis, polycythaemia, pulmonary haemorrhage, and an increased risk of congenital abnormality, have been reported in small for dates infants.3 Ounsted et al found that only 35% of a cohort of infants more than 2 standard deviations below the mean birth weight for gestation had an uncomplicated neonatal course, and their neonatal mortality was 63 per 1000 live births.4 In recent years, however, our impression has been that with improved standards of obstetrics and routine neonatal care, small for dates infants other than those with complications attributable to short gestation have caused few problems.
Patients and methods
It is our policy to admit to the neonatal unit only babies who have symptoms or who weigh <1800 g; asymptomatic babies above this weight go to the postnatal wards irrespective of gestation or whether they are small for dates or not.
Since 1975 the routine on the postnatal wards in the Cambridge Maternity Hospital has been to record Dextrostix (Ames, United Kingdom) routinely at 2, 6, 12, 24, 36, and 48 hours of age in all babies below the 2.3rd centile. Dextrostix are performed in bigger infants at the discretion of the nursing or medical staff. As well as having these Dextrostix measurements the babies receive 60 ml/kg of formula on day 1 and 90 ml/kg on day 2, plus whatever they receive from the breast.5 In this study we have reviewed all 164 infants born in 1982 at Cambridge Maternity Hospital at gestations of 37 or more weeks (259 days or more) whose birth weights were below the fifth centile of Tanner and Thomson.6 These infants were termed 'small for dates. The mothers' and infants' notes were scrutinised for the presence of an antenatal diagnosis of poor growth, intrapartum asphyxia, intubation at birth, hypothermia (<36°C), hypoglycaemia (glucose concentration < 1 .4 mmol/l (25 mg/100 ml on Dextrostix)), need for admission to the neonatal unit, and any neonatal illness.
For analysis, infants were divided into those above or below the 2-3rd centile of Milner and Richards7 (equivalent to 2 SD below the mean birth weight for gestation). The x2 test was used for comparing frequency distributions using Yates's correction for small numbers.
To extend our assessment of the safety of our practice we reviewed our records to find all those infants admitted to our neonatal unit with symptomatic hypoglycaemia during the six year period 1977-82, during which our postnatal ward routine was that described above. The neonatal problems are summarised in Table  1 . Thirteen infants (8%) were admitted to the neonatal unit for the reasons shown in Table 2 , and It has to be emphasised, however, that most of these studies were from an era when neither early feeding of small for dates infants was pursued with the enthusiasm that was fostered by the studies of Smallpiece and Davies13 nor monitoring for asymptomatic hypoglycaemia in small for dates infants by Dextrostix was routine. In 1982 we reported a very low incidence (5/167 (3%)) of asymptomatic hypoglycaemia using the above protocol in infants with a birth weight of 1800-2500 g (about half of whom were small for dates) nursed on a postnatal ward.14 A similarly low incidence of hypoglycaemia in adequately fed small for dates infants was reported by Walther and Ramaekers.'5 This present study, provoked, in part, by the persisting controversy over our 1982 data that adequately fed and monitored small for dates babies could be safely cared for on a postnatal ward, confirms that even asymptomatic hypoglycaemia is rare (9/164 (5%)) in small for dates infants. Those who are asymptomatic and with their mothers on a postnatal ward respond promptly to an extra feed. No small for dates infant in this study or that of Whitby et al'4 developed symptomatic hypoglycaemia.
As it is uncertain whether jitteryness is a specific feature of neuroglycopenia or whether it is caused by 'smallness-for-dates' itself, we failed to diagnose hypoglycaemia before symptoms (fits) occurred in only three infants in the six year period 1977-82. None of them was below even the 10th birthweight centile for gestation, and none would, therefore, have been included in any currently recommended screening programme for detecting hypoglycaemia in small for dates infants.
Whether we missed any cases of asymptomatic hypoglycaemia in the period 1977-82 remains speculative. As there is no evidence that asymptomatic hypoglycaemia is associated with any long term sequelae3 we believe that detecting a biochemical abnormality of no clinical importancethat is, transient self correcting asymptomatic hypoglycaemia-serves no purpose. Furthermore, the data show that no small for dates infant with asymptomatic hypoglycaemia can have subsequently developed symptomatic hypoglycaemia (fits) in this six year period.
In the 1977-82 data only one infant was found with a weight between the 2-3rd and 5th centile who became hypoglycaemic and who required any treatment other than an extra feed to maintain a normal blood glucose concentration. As 
